Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-06-12 Hillsberg Sanford Director Grant or award · Stock Option (right to buy) +35,000 35,000
2015-06-08 Henderson Molly Chief Financial Officer Grant or award · Stock Option +200,000 200,000
2015-05-06 Hillsberg Sanford Director Sale −50,000 $10.00 $500K 219,000
2015-05-01 Ayer Capital Management, LP 10% owner Sale −2,780,682 $9.62 $26.8M 2,823,333
2015-02-28 HAWKINS ELMA President and CEO Exercise or conversion +40,000 200,555
2015-02-28 HAWKINS ELMA President and CEO Shares withheld for taxes −23,988 $8.98 $215K 176,567
2015-02-28 HAWKINS ELMA President and CEO Exercise or conversion · Restricted Stock −40,000 160,000
2015-02-16 Maynard Ryan D Director Grant or award · Stock Option (right to buy) +50,000 50,000
2015-01-28 Hillsberg Sanford Director Other disposition −25,000 0
2015-01-28 Hillsberg Sanford Director Other disposition · Warrant −25,000 0
2014-12-16 Hillsberg Sanford Director Grant or award +25,000 25,000
2014-12-16 Hillsberg Sanford Director Grant or award · Warrant +25,000 25,000
2014-12-05 Radvanyi Laszlo Chief Scientific Officer Grant or award · Stock Option (right to buy) +32,407 32,407
2014-12-05 Venkatesan Jay Director Grant or award · Stock Option (right to buy) +50,000 50,000
2014-12-05 MCPEAK MERRILL A Director Grant or award · Stock Option (right to buy) +50,000 50,000
2014-12-05 Handelman Michael D Chief Financial Officer Grant or award · Stock Option (right to buy) +40,000 40,000
2014-12-05 Bender James G. Vice President, Manufacturing Grant or award · Stock Option (right to buy) +46,666 46,666
2014-12-05 Hillsberg Sanford Director Grant or award · Stock Option (right to buy) +50,000 50,000
2014-11-06 BRISTOL INVESTMENT FUND LTD 10% owner Sale −100,000 $690,000.00 $69.0B 3,867,863
2014-08-21 HAWKINS ELMA President & COO Grant or award · Stock Option (right to buy) +125,000 125,000

Page 28 of 31 · 605 trades